CHRISTEN GREUEL: Open Payments
NPI 1740712348 · CLAREMORE, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,900 in 104 payments from 23 companies in 2025. Trend: 2023 $1,936 · 2024 $2,271 · 2025 $1,900
Food & beverage: $1,900
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 20 | $356 |
| PFIZER INC. | 12 | $214 |
| Otsuka America Pharmaceutical, Inc. | 4 | $184 |
| Lilly USA, LLC | 11 | $176 |
| ABBVIE INC. | 10 | $148 |
| Amgen Inc. | 6 | $110 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $96 |
| AstraZeneca Pharmaceuticals LP | 6 | $87 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $68 |
| Lundbeck LLC | 4 | $61 |
Products named: REXULTI, MOUNJARO, ELIQUIS, Wegovy, Ozempic, CAPLYTA, NURTEC ODT, UBRELVY.
Industry payments across OK — which companies pay providers there.
